Garvan News Professor Jonathan Sprent Top Ranked NHMRC Research Fellow for 201010 Mar 2010 Last week, NHMRC announced awards for the highest ranked recipients of grants and fellowships for 2010. Garvan Immunologist Professor Jonathan Sprent received the Achievement Award as the Top Ranked NHMRC Research Fellow. MoreSurprising findings about Hepatitis C and insulin resistanceMEDIA RELEASE: 09 Mar 2010 Researchers at Garvan have now confirmed the link between Hepatitis C and Type 2 diabetes - people with the virus being 3 to 4 times more likely to develop diabetes, owing to high levels of insulin resistance in muscle. There is practically no insulin resistance in the liver, however, a surprising finding given that Hepatitis C is a liver disease. MoreWhat it might take to unravel the ‘lean mean machine’ that is cancerMEDIA RELEASE: 22 Feb 2010 Garvan scientists have published a paper, online today in Nature Cell Biology, describing gene expression in a prostate cancer cell: more sweeping, more targeted and more complex than we could ever have imagined, even five years ago. MoreRaising the question of obesity in AsiaMEDIA RELEASE: 12 Feb 2010 When it comes to obesity, it would seem that it’s very important to define terms, and equally important to ask questions about those terms. So say Garvan scientists and their American and Vietnamese collaborators who challenge findings published in 1994 which concluded that for a given Body Mass Index, Asians have a higher percentage of body fat than Caucasians. MoreHow ‘lipid rafts’ help us mount an immune responseMEDIA RELEASE: 08 Feb 2010 Garvan immunologists have found that lipid rafts, hot spots of signalling activity in our cells, ramp up the sensitivity of certain immune cells, helping us mount an immune response MoreDA Approval for Major Australian Cancer CentreMEDIA RELEASE: 17 Jan 2010 The Garvan Institute of Medical Research and St Vincent’s Hospital today welcomed the NSW Government’s approval of their development proposal for the Garvan St Vincent’s Cancer Centre lodged before the NSW Department of Planning. MoreHow a single molecule gives our immune systems their memoryMEDIA RELEASE: 11 Jan 2010 By studying the blood cells of people with an immunodeficiency disorder, scientists at Garvan have been able to identify the molecular mechanisms that lead to the production of antibodies in human B cells. This has wider implications for potential treatment of certain cancers and autoimmune diseases. MoreSetting the record straight on weight lossMEDIA RELEASE: 06 Jan 2010 It’s time to set the record straight. The only reliable way to lose weight is to eat less or exercise more. Preferably both. So why bother to state the obvious? Because a body of scientific literature has arisen over recent years, suggesting that fat oxidation – burning the fats we eat as opposed to the carbohydrates – is enough to promote fat loss. It isn’t. More |
Events Healthy Ageing Public Seminar25 May 2010
Public Seminar
Diabetes Public Seminar19 Aug 2010
Public Seminar
UICC World Cancer Declaration Garvan is a member of the International Union Against Cancer (UICC), a global advocacy and educational organisation striving to reduce cancer incidence.
Women with osteoporosis required for study We are recruiting patients for a new study. Specifically, we are looking for women being treated for post menopausal osteoporosis who have had problems taking older oral medications regularly. Please click here to see details. Garvan St. Vincent's Cancer Centre "Please help us raise the funds we need to build this wonderful new facility to bring research and care together under one roof" Delta Goodrem, Centre Patron
For more information visit the Cancer Centre website. Garvan Links TOUR GARVAN
FRACTURE RISK CALCULATORBased on data from the 18-year Dubbo Osteoporosis Epidemiology Study. For men and women 60 years and over to assess their individual risk of fracture. www.fractureriskcalculator.com
AUSTRALIAN PANCREATIC CANCER GENOME INITIATIVEGarvan is involved in the Australian arm of the The International Cancer Genome Consortium – by investigating pancreatic cancer. For more information click here. |
